Toronto Dominion Bank increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 5.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 70,696 shares of the medical device company's stock after buying an additional 3,924 shares during the quarter. Toronto Dominion Bank's holdings in Cooper Companies were worth $6,499,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Covestor Ltd grew its stake in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the last quarter. Shell Asset Management Co. raised its holdings in Cooper Companies by 15.5% during the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after purchasing an additional 127 shares during the last quarter. Torray Investment Partners LLC raised its holdings in shares of Cooper Companies by 0.8% in the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock worth $1,488,000 after acquiring an additional 132 shares during the last quarter. Mather Group LLC. raised its holdings in shares of Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock worth $177,000 after acquiring an additional 133 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in shares of Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after acquiring an additional 136 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.
Cooper Companies Price Performance
Shares of COO traded down $0.47 during trading hours on Friday, hitting $78.83. 1,548,951 shares of the company were exchanged, compared to its average volume of 1,493,548. The company has a market capitalization of $15.76 billion, a PE ratio of 40.43, a PEG ratio of 2.25 and a beta of 1.08. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a fifty day simple moving average of $80.25 and a 200-day simple moving average of $89.24. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38.
Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.
Analyst Ratings Changes
Several research firms recently commented on COO. Robert W. Baird dropped their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Citigroup decreased their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Stifel Nicolaus reduced their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Piper Sandler reissued an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Finally, Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Thursday. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and an average price target of $110.25.
View Our Latest Analysis on COO
About Cooper Companies
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
